Marty Allain, Chair
Marty Allain serves as the Senior Manager for the .Pharmacy Verified Websites Program at the National Association of Boards of Pharmacy (NABP). The .Pharmacy Verified Websites Program identifies online pharmacies and pharmacy-related websites around the globe as safe and legitimate.
Elizabeth Miller, Treasurer
Elizabeth Miller, PharmD, serves as Vice President for U.S. Regulatory Affairs at the U.S. Pharmacopeial Convention (USP), where she leads USP’s strategic engagement and collaboration with the U.S. Food and Drug Administration (FDA) and other domestic regulatory agencies and stakeholders.
Bruce Longbottom, Secretary
Bruce Longbottom has served as an Assistant General Counsel – Trademarks at Eli Lilly and Company since 2001, where he works on the company’s global anticounterfeiting efforts. He also has been active in the International Trademark Association (INTA), having served on the INTA Board and as the Chair of INTA’s Anti-Counterfeiting Committee. Bruce also serves on the Executive Board and Registrant/Supporter Advisory Committee supporting the .Pharmacy initiative of the National Association of Boards of Pharmacy (NABP).
Elizabeth Scofield, Board Member
Elizabeth Scofield heads up Visa’s Global Brand Protection Program, which identifies illegal or brand damaging merchants within the payments system. Elizabeth also produces and executes policy and educational materials which aid Visa’s clients in managing their merchant underwriting, monitoring and compliance programs.
Libby L. Baney
Libby Baney is a principal with Faegre Baker Daniels Consulting. As a senior advisor to the Alliance for Safe Online Pharmacies (ASOP Global) and ASOP Global Foundation she helps shape public policy and promote increased international attention to the issue of illegal online pharmacies and counterfeit medicines in the U.S., EU and Asia. Libby’s work at Faegre Baker Daniels is focused on Internet pharmacies and pharmacy compliance; telemedicine and telehealth; pharmaceutical supply chain security and integrity; falsified and counterfeit medicines; mobile health; Internet governance and ICANN policy; new generic top-level domain (gTLDs) policy; Food and Drug Administration (FDA) regulatory and user fee reforms; and international regulatory harmonization and capacity building.
Tricia A. Beckmann
Tricia Beckmann is an ASOP Global Foundation advisor and a Director at Faegre Baker Daniels Consulting, where she works with clients throughout the healthcare industry on state and federal health care regulatory issues in the FaegreBD’s Health and Biosciences Practice. Tricia has in-depth knowledge of the health care industry, particularly the industry’s relationship with regulatory bodies, through positions with both government agencies and healthcare stakeholders, including the Centers for Medicare and Medicaid Services (CMS).